Overruled: No More Dual Pricing

Gopal,Kevin;

Article

Pharmaceutical Executive

July 1, 2001

Pharmaceutical Executive

Pharmaceutical Executive-07-01-2001

Volume0

Issue 0

Overruled: No More Dual Pricing

Author(s):

Kevin Gopal

European Union-The European Commission’s ban on GlaxoSmith–Kline’s dual pricing policy in Spain halts one of Big Pharma’s attempts to prevent parallel imports in Europe.

Articles in this issue

Pharmacies: OTC Price Wars

One Disease at a Time

Overview of the Industry: A World of Opportunities

The Power Shift

A Giant Stumbles

Overruled: No More Dual Pricing

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Videos